Q3 2023 Novozymes A/S Earnings Call Transcript

Oct 26, 2023 / 07:00AM GMT
Operator

Welcome to the Novozymes conference call regarding the interim report for the first 9 months of 2023. (Operator Instructions)

Today, I am pleased to leave the word to Tobias Cornelius Björklund, Head of Investor Relations. Please begin your meeting.

Tobias Cornelius Bjorklund - Novozymes A/S-Head of IR

Thank you, operator, and welcome, everyone, to Novozymes conference call for the first 9 months of 2023. My name is, as mentioned, Tobias Björklund, and I'm heading up Investor Relations here at Novozymes. At this call, our CEO, Ester Baiget; and our CFO, Lars Green, will review our performance and key events of the first 9 months of the year as well as the outlook for the full year. Also attending today's call are Tina Fanoe, EVP, Agriculture & Industrial Biosolutions; Amy Byrick, EVP, Strategy and Business Transformation; Anders Lund, EVP, Consumer Biosolutions; and Claus Fuglsang, CSO and EVP of Research and Development. Then entire call will take about 60 minutes, including time for questions at the end.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot